Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-010650
Filing Date
2021-03-04
Accepted
2021-03-03 19:03:20
Documents
8
Period of Report
2021-03-03

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210303.htm 6-K 17580
2 EX-99.1 bntx-ex991_7.htm EX-99.1 39192
3 GRAPHIC gg3ydf13vmxa000002.jpg GRAPHIC 780
4 GRAPHIC gpcy5u2kahak000002.jpg GRAPHIC 9298
5 GRAPHIC gg3ydf13vmxa000003.jpg GRAPHIC 780
6 GRAPHIC gpcy5u2kahak000001.jpg GRAPHIC 14710
7 GRAPHIC gg3ydf13vmxa000001.jpg GRAPHIC 780
8 GRAPHIC gg3ydf13vmxa000004.jpg GRAPHIC 780
  Complete submission text file 0001564590-21-010650.txt   96046
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21711494
SIC: 2836 Biological Products, (No Diagnostic Substances)